previous compound ID: 2563 next compound
InChIKey: XDXDZDZNSLXDNA-TZNDIEGXSA-N
SMILES: C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C(C4=C(C(=C23)O)C(=O)C5=CC=CC=C5C4=O)O)(C(=O)C)O)N)O

biological descriptors:

CFTR relevance: unspecified

Category:
Influence on CFTR function unknown
Order of interaction unknown
subcellular compartment unknown

reference list:

ReferenceID: 53
"J Liao" "GW Carlile" "B Kus" "E Matthes" "DY Thomas" "R Robert" "JW Hanrahan" "J Goepp" "SD Macknight" "D Rotin"

chemical graph of compound 2563





CID is 42890
synonyms found at PubChem are:
IDARUBICIN, 58957-92-9, 4-Demethoxydaunorubicin, Idarubicina, 4-Demethoxydaunomycin, Idarubicinum, Idarubicine, Idamycin, Idarubicin Hcl, Idarubicine [INN-French], Idarubicinum [INN-Latin], Idarubicina [INN-Spanish], Idarubicin [INN:BAN], IMI 30, IMI-30, 4-Desmethoxydaunorubicin, Daunomycin, 4-demethoxy-, UNII-ZRP63D75JW, Idarubicin (INN), Idarubicin Hcl Pfs, Zavedos (TN), Zavedos, NSC-256439, CCRIS 5083, 4-DMD, ZRP63D75JW, CHEBI:42068, 5,12-Naphthacenedione, 9-acetyl-7-((3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,9,11-trihydroxy-, (7S-cis)-, Idamycin PFS, Idamycin (TN), DMDR, I 1656, (1S,3S)-3-acetyl-3,5,12-trihydroxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranoside, DM5, MLS001401448, (7S,9S)-9-acetyl-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-6,9,11-trihydroxy-8,10-dihydro-7H-tetracene-5,12-dione, (7S,9S)-9-acetyl-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-8,10-dihydro-7H-tetracene-5,12-dione, (7S,9S)-9-acetyl-7-{[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy}-6,9,11-trihydroxy-5,7,8,9,10,12-hexahydrotetracene-5,12-dione, 5,12-Naphthacenedione, 7,8,9,10-tetrahydro-9-acetyl-7-((3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-6,9,11-trihydroxy-, (7S-cis)-, C26H27NO9, NCGC00093976-03, SMR000466355, SR-01000075934, demethoxydaunorubicin, (7S-cis)-9-Acetyl-7-[(3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,9,11-trihydroxy-5,12-naphthacenedione, D01XDL, AC1L28SA, AC1Q6JJ4, SCHEMBL3750, CHEMBL1117, Lopac0_000600, KBioSS_002388, Idarubicin hydrochloride, solid, cid_636362, GTPL7083, DTXSID7023142, IDARUBICIN(Hydrochloride form), BDBM58490, MolPort-006-167-730, XDXDZDZNSLXDNA-TZNDIEGXSA-N, BCPP000207, HMS2089D05, HMS3261H22, ZINC3920266, Tox21_500600, AKOS015895563, AC-9384, API0002970, BCP9000773, CCG-204689, DB01177, LP00600, NCGC00093976-01, NCGC00093976-02, NCGC00093976-04, NCGC00093976-05, NCGC00261285-01, 57852-57-0 (HYDROCHLORIDE), AN-11145, CC-29462, LS-94015, SC-17016, EU-0100600, FT-0621481, D08062, Z-3092, 15158-EP2270008A1, 15158-EP2272827A1, 15158-EP2275420A1, 15158-EP2277879A1, 15158-EP2280012A2, 15158-EP2281815A1, 15158-EP2289892A1, 15158-EP2292615A1, 15158-EP2292617A1, 15158-EP2295055A2, 15158-EP2295416A2, 15158-EP2295426A1, 15158-EP2295427A1, 15158-EP2298748A2, 15158-EP2298764A1, 15158-EP2298765A1, 15158-EP2301928A1, 15158-EP2301933A1, 15158-EP2305640A2, 15158-EP2305642A2, 15158-EP2305671A1, 15158-EP2308833A2, 15158-EP2308855A1, 15158-EP2311453A1, 15158-EP2311808A1, 15158-EP2311825A1, 15158-EP2311827A1, 15158-EP2311829A1, 15158-EP2311842A2, 15158-EP2316832A1, 15158-EP2316833A1, AB00698511-06, AB00698511-08, AB00698511-09, AB00698511-10, AB00698511_11, 957I929, A832088, C-22925, I06-1097, SR-01000075934-1, BRD-K69650333-001-01-1, BRD-K69650333-001-02-9, BRD-K69650333-003-14-0, Idarubicin, United States Pharmacopeia (USP) Reference Standard, (1S,3S)-3-acetyl-3,5,12-trihydroxy-6,11-dioxo-1,2,3,4,6,11-hexahydronaphthacen-1-yl 3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranoside, (1s,3s)-3-acetyl-3,5,12-trihydroxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-|A-l-lyxo-hexopyranoside, (1s,3s)-3-acetyl-3,5,12-trihydroxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-A-l-lyxo-hexopyranoside, (7S,9S)-7-[(2R,4S,5S,6S)-4-azanyl-6-methyl-5-oxidanyl-oxan-2-yl]oxy-9-ethanoyl-6,9,11-tris(oxidanyl)-8,10-dihydro-7H-tetracene-5,12-dione, (7S,9S)-7-[(2R,4S,5S,6S)-4-azanyl-6-methyl-5-oxidanyl-oxan-2-yl]oxy-9-ethanoyl-6,9,11-tris(oxidanyl)-8,10-dihydro-7H-tetracene-5,12-dione;hydrochloride, (7S,9S)-9-acetyl-7-((2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyltetrahydro-2H-pyran-2-yloxy)-6,9,11-trihydroxy-7,8,9,10-tetrahydrotetracene-5,12-dione, (7S,9S)-9-acetyl-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-6,9,11-trihydroxy-8,10-dihydro-7H-tetracene-5,12-quinone;hydrochloride, (7S,9S)-9-acetyl-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-8,10-dihydro-7H-tetracene-5,12-dione;hydrochloride, (7S,9S)-9-acetyl-7-[[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyl-2-oxanyl]oxy]-6,9,11-trihydroxy-8,10-dihydro-7H-tetracene-5,12-dione, (7S,9S)-9-acetyl-7-[[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyl-2-oxanyl]oxy]-6,9,11-trihydroxy-8,10-dihydro-7H-tetracene-5,12-dione;hydrochloride, 4-Demethoxydaunorubicin|||IMI-30|||NSC-256439|||(7S,9S)-9-Acetyl-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-8,10-dihydro-7H-tetracene-5,12-dione, 5,12-Naphthacenedione, 7,8,9,10-tetrahydro-9-acetyl-7-((3-amino-2,3,6-trideoxy-.alpha.-L-lyxo-hexopyranosyl)oxy)-6,9,11-trihydroxy-, (7S-cis)-